Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
PURPOSE: Identification of prognostic factors in patients with malignant pleural mesothelioma based on prospectively collected international data. PATIENTS AND METHODS: From October 1984 to October 1993, 204 eligible adult patients with malignant pleural mesothelioma were entered into five consecutive prospective European Organization for Research and Treatment of Cancer (EORTC) phase II clinical trials designed to assess the efficacy of various anticancer drugs (mitoxantrone, epidoxorubicin, etoposide, and paclitaxel). The Cox model was used to assess 13 factors related to biology and disease history with respect to survival. RESULTS: The median survival duration was 12.6 months from diagnosis and 8.4 months from trial entry. In the multivariate analysis, poor prognosis was associated with a poor performance status, a high WBC count, a probable/possible histologic diagnosis of mesothelioma, male gender, and having sarcomatous tissue as the histologic subtype. Taking these five factors into consideration, patients were classified into two groups: a good-prognosis group (1-year survival rate, 40%; 95% confidence interval [CI], 30% to 50%) and a poor-prognosis group (1-year survival, 12%; 95% CI, 4% to 20%). CONCLUSION: These results may help to design new clinical trials in pleural mesothelioma by selecting more homogenous groups of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Linear Statistical Inference and its Applications: Second Editon
Rao, C. R. (1973) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316436 · Cited by 10,489
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 728
Statistical aspects of prognostic factor studies in oncology
Simon, R., & Altman, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.192 · Cited by 582
Regression models for prognostic prediction: advantages, problems, and suggested solutions.
Fe, H., Kl, L., Matchar, D. B., & Ta, R. (1985) · PubMed · Cited by 559
Mossman, B. T., & Gee, J. B. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202604 · Cited by 497
Diffuse Malignant Mesothelioma: Prospective Evaluation of 69 Patients
CHAHINIAN, A. P., PAJAK, T. F., HOLLAND, J. F., NORTON, L., AMBINDER, R. M., & MANDEL, E. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-6-746 · Cited by 354
Antman, K. H., Shemin, R. J., RYAN, L. M., Klegar, K., Osteen, R. T., Herman, T., Lederman, G. S., & Jm, C. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.147 · Cited by 289
Occupational exposure to asbestos: Population at risk and projected mortality‐1980–2030
Nicholson, W. J., Perkel, G., & Selikoff, I. J. (1982) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700030305 · Cited by 289
Rusch, V. W., Piantadosi, S., & Holmes, E. C. (1991) · PubMed · Cited by 264
Sugarbaker, D. J., Strauss, G. M., Lynch, T. J., Richards, W., Mentzer, S. J., Lee, T. H., Corson, J. M., & Antman, K. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1172 · Cited by 246
Sugarbaker, D. J., Garcia, J. P., Richards, W. G., Harpole, D. H., Healy-Baldini, E., DeCamp, M. M., Mentzer, S. J., Liptay, M. J., Strauss, G. M., & Swanson, S. J. (1996) · Annals of Surgery · doi:10.1097/00000658-199609000-00005 · Cited by 237
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
Alberts, A. S., Falkson, G., Goedhals, L., Vorobiof, D. A., & Van der Merwe, C. A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.3.527 · Cited by 230
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
Wagner, J. C., Sleggs, C. A., & Marchand, P. (1960) · Occupational and Environmental Medicine · doi:10.1136/oem.17.4.260 · Cited by 182
Antman, K. H. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007243030407 · Cited by 171
Malignant Mesothelioma of the Pleura
PISANI, R. J., COLBY, T. V., & WILLIAMS, D. E. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65411-1 · Cited by 167
Chahinian, A. P. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90394-8 · Cited by 128
Prognostic Factors in Diffuse Malignant Pleural Mesothelioma
Chailleux, E., Dabouis, G., Pioche, D., Lajartre, M. D., de Lajartre, A.-Y., Rembeaux, A., & Germaud, P. (1988) · CHEST Journal · doi:10.1378/chest.93.1.159 · Cited by 125
Survival patterns for malignant mesothelioma: The seer experience
Spirtas, R., Connelly, R. R., & Tucker, M. A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410409 · Cited by 123
Gastl, G. A., Plante, M., Finstad, C. L., Wong, G. Y., Federici, M. G., Bander, N. H., & Rubin, S. C. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04668.x · Cited by 109
Pepper, C. J., Jasani, B., Navabi, H., Wynford‐Thomas, D., & Gibbs, A. R. (1996) · Thorax · doi:10.1136/thx.51.11.1074 · Cited by 96
van Meerbeeck, J. P., Debruyne, C., van Zandwijk, N., Postmus, P. E., Pennucci, M. C., van Breukelen, F., Galdermans, D., Groen, H. J. M., Pinson, P., Glabbeke, M. M. V., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.465 · Cited by 81
Self-citationFitzpatrick, D. R., Peroni, D. J., & Bielefeldt-Ohmann, H. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.5.7742009 · Cited by 79
Samson, M. K., Wasser, L. P., Borden, E. C., Wanebo, H. J., Creech, R. H., Phillips, M., & Baker, L. H. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.86 · Cited by 72
Mattson, K. V., Giaccone, G., Kirkpatrick, A., Evrard, D., Tammilehto, L., van Breukelen, F. J. M., Planteydt, H. T., & van Zandwijk, N. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.824 · Cited by 61
Self-citationSahmoud, T., Postmus, P. E., van Pottelsberghe, C., Mattson, K. V., Tammilehto, L., Splinter, T. A. W., Planting, A. S. T., Sutedja, T. G., von Pawel, J., van Zandwijk, N., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00183-4 · Cited by 48
Self-citationHigashihara, M., Sunaga, S., Tange, T., Oohashi, H., & Kurokawa, K. (1992) · Cancer · Cited by 44
Epidemiological and quantitative relationships between mesothelioma and asbestos on Tyneside
Ashcroft, T. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.26.11.832 · Cited by 36
Graham, M. V., Geitz, L. M., Byhardt, R. W., Asbell, S., Roach, M., Urtasun, R. C., Curran, W. J., Lattin, P. B., Russell, A. H., & Cox, J. D. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.22.1731 · Cited by 31
Rochlitz, C. F., Lobeck, H., Peter, S., Reuter, J., Mohr, B., de Kant, E., Huhn, D., & Herrmann, R. (1992) · Cancer · doi:10.1002/1097-0142(19920615)69:12<2975::aid-cncr2820691218>3.0.co;2-a · Cited by 26
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Zalcman, G., Mazieres, J., Margery, J., Greillier, L., Audigier-Valette, C., Moro-Sibilot, D., Molinier, O., Corre, R., Monnet, I., Gounant, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01238-6 · Cited by 968
Robinson, B. W., Musk, A. W., & Lake, R. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67025-0 · Cited by 664
Scherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
Self-citationHusain, Colby, Ordóñez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0124-ra · Cited by 619
van Meerbeeck, J. P., Gaafar, R., Manegold, C., Van Klaveren, R. J., Van Marck, E. A., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.20005.14.589 · Cited by 617
Self-citation
Metadata
- Authors
- Curran, D., Sahmoud, T., Therasse, P., van Meerbeeck, J., Postmus, P. E., & Giaccone, G.
- Venue
- Journal of Clinical Oncology
- Published
- 1998-01
- Volume
- 16
- Issue
- 1
- Pages
- 145-152
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2101834873
- Cited by
- 543
- References
- 34
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.